Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
CALL
Royal Gold
RGLD
$17.1B
| $3.29M | ﹤0.01% |
64,100
+19,100
| +42% | +$779K |
|
3027
PUT
United Therapeutics
UTHR
$25.7B
| $3.29M | ﹤0.01% |
29,500
-6,700
| -19% | -$848K |
|
3028
Axos Financial
AX
$5.93B
| $3.29M | ﹤0.01% |
154,009
+43,956
| +40% | +$796K |
|
3029
PUT
Advanced Micro Devices
AMD
$790B
| $3.28M | ﹤0.01% |
1,151,800
-11,229,500
| -91% | -$25.5M |
|
3030
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.54B
| $3.28M | ﹤0.01% |
133,600
-71,200
| -35% | -$1.65M |
|
3031
PUT
iShares MSCI Mexico ETF
EWW
$1.96B
| $3.28M | ﹤0.01% |
61,000
-311,300
| -84% | -$15.1M |
|
3032
DNOW Inc
DNOW
$2.6B
| $3.27M | ﹤0.01% |
184,719
+34,904
| +23% | +$537K |
|
|
NGD
3033
DELISTED
New Gold Inc
NGD
| $3.27M | ﹤0.01% |
876,946
+374,734
| +75% | +$1.12M |
|
3034
CALL
Credit Acceptance
CACC
$6.03B
| $3.27M | ﹤0.01% |
+18,000
| New | +$3.43M |
|
3035
PUT
Western Union
WU
$2.04B
| $3.26M | ﹤0.01% |
169,200
+124,700
| +280% | +$2.24M |
|
3036
Banco Santander Chile
BSAC
$16.3B
| $3.26M | ﹤0.01% |
168,499
+28,280
| +20% | +$499K |
|
|
SN
3037
DELISTED
Sanchez Energy Corporation
SN
| $3.26M | ﹤0.01% |
593,716
-356,365
| -38% | -$1.38M |
|
|
VSI
3038
DELISTED
Vitamin Shoppe Inc.
VSI
| $3.25M | ﹤0.01% |
104,812
+63,278
| +152% | +$1.9M |
|
3039
PUT
NextEra Energy
NEE
$179B
| $3.24M | ﹤0.01% |
109,600
-73,200
| -40% | -$2.05M |
|
3040
PUT
Thomson Reuters
TRI
$44.5B
| $3.24M | ﹤0.01% |
+68,936
| New | +$2.96M |
|
|
ELLI
3041
PUT
DELISTED
Ellie Mae Inc
ELLI
| $3.24M | ﹤0.01% |
+35,700
| New | +$2.67M |
|
3042
PUT
O'Reilly Automotive
ORLY
$73.3B
| $3.23M | ﹤0.01% |
177,000
+154,500
| +687% | +$2.64M |
|
|
ITG
3043
DELISTED
Investment Technology Group Inc
ITG
| $3.22M | ﹤0.01% |
145,844
-79,416
| -35% | -$1.45M |
|
|
FPRX
3044
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.22M | ﹤0.01% |
+79,300
| New | +$2.73M |
|
|
BGG
3045
DELISTED
Briggs & Stratton Corp.
BGG
| $3.22M | ﹤0.01% |
134,636
+74,134
| +123% | +$1.53M |
|
3046
Global Net Lease
GNL
$1.83B
| $3.22M | ﹤0.01% |
125,318
+95,554
| +321% | +$2.18M |
|
3047
PUT
Martin Marietta Materials
MLM
$32.6B
| $3.21M | ﹤0.01% |
20,100
+6,900
| +52% | +$948K |
|
|
FIT
3048
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $3.21M | ﹤0.01% |
211,600
-442,000
| -68% | -$7.02M |
|
|
ASRT
3049
DELISTED
Assertio
ASRT
| $3.2M | ﹤0.01% |
3,826
-2,583
| -40% | -$2.4M |
|
3050
PUT
CSX Corp
CSX
$92.1B
| $3.2M | ﹤0.01% |
372,300
-253,800
| -41% | -$2.06M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.